Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

GIORDANO Catello KENDLER Jonatan SEXL Maximilian KOLLMAN Sebastian VARENICJA Maxim SZABO Boglarka TIMELTHALER Gerald KIRCHHOFER Dominik HOLLOCZKI Oldamur TURNER Suzanne Dawn MORIGGL Richard KENNER Lukas TOUAIBIA Mohamed MERKEL Olaf

Year of publication 2025
Type Article in Periodical
Magazine / Source Redox Biology
MU Faculty or unit

Faculty of Medicine

Citation
web https://www.sciencedirect.com/science/article/pii/S2213231725000953?via%3Dihub
Doi http://dx.doi.org/10.1016/j.redox.2025.103582
Keywords Centrosome; Caffeic Acid Phenethyl Ester
Description Anaplastic Large Cell Lymphoma (ALCL) is an aggressive T-cell lymphoma affecting children and young adults. About 30% of patients develop therapy resistance therefore new precision medicine drugs are highly warranted. Multiple rounds of structure-activity optimization of Caffeic Acid Phenethyl Ester have resulted in CM14. CM14 causes upregulation of genes involved in oxidative stress response and downregulation of DNA replication genes leading to G2/M arrest and subsequent apoptosis induction. In accordance with this, an unbiased proteomics approach, confocal microscopy and molecular modeling showed that TUBGCP2, member of the centrosomal gamma-TuRC complex, is a direct interaction partner of CM14. CM14 overcomes ALK inhibitor resistance in ALCL and is also active in T-cell Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia. Interestingly, CM14 also induced cell death in docetaxel-resistant prostate cancer cells thus suggesting an unexpected role in solid cancers. Thus, we synthesized and thoroughly characterized a novel TUBGCP2 targeting drug that is active in ALCL but has also potential for other malignancies.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info